Komori
KYORIN Pharmaceutical (4569) · RiskMitigated

Guarantee Loss on the Employee Shareholding Incentive Plan

First written in FY2018. 1 of 2 entries say "Materialised", first in FY2018. Latest entry: FY2019.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY20182018: 120182019: 12019
Same theme, other companies
Company Repayment Risk from a Decline in the Share Price of an Employee Stock Ownership Trust’s HoldingsA theme 64 companies write about · 64 as a headwind · 0 as a tailwind

31 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 64 companies compared. The sentences above are computed from all 64.
Moved together

"Declines in Revenue and Profit Due to Drug Price Revisions, Lower License Income and Other Factors" moved the same way as this thread, in the same document, in 2 of its 2 moves.

2★1
  1. ★This thread
  2. 1Declines in Revenue and Profit Due to Drug Price Revisions, Lower License Income and Other Factors2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Guarantee Loss on the Employee Shareholding Incentive Plan | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori